Skip to main content

Page of 2 next disabled
and
  1. Article

    Open Access

    Preclinical development of a bispecific TNFα/IL-23 neutralising domain antibody as a novel oral treatment for inflammatory bowel disease

    Anti-TNFα and anti-IL-23 antibodies are highly effective therapies for Crohn’s disease or ulcerative colitis in a proportion of patients. V56B2 is a novel bispecific domain antibody in which a llama-derived IL...

    Kevin J. Roberts, Marion F. Cubitt, Timothy M. Carlton in Scientific Reports (2021)

  2. Article

    Open Access

    Identification of gut microbial species linked with disease variability in a widely used mouse model of colitis

    Experimental mouse models are central to basic biomedical research; however, variability exists across genetically identical mice and mouse facilities making comparisons difficult. Whether specific indigenous ...

    Samuel C. Forster, Simon Clare, Benjamin S. Beresford-Jones in Nature Microbiology (2022)

  3. Article

    Open Access

    Tissue-resident B cells orchestrate macrophage polarisation and function

    B cells play a central role in humoral immunity but also have antibody-independent functions. Studies to date have focused on B cells in blood and secondary lymphoid organs but whether B cells reside in non-ly...

    Ondrej Suchanek, John R. Ferdinand, Zewen K. Tuong in Nature Communications (2023)

Page of 2 next disabled